Biotech

All Articles

Cassava pays $40M over allegedly deceiving Alzheimer's update

.Cassava Sciences has accepted spend $40 thousand to deal with an investigation in to cases it made ...

Merck bags possibilities on Evaxion's AI-designed vaccination candidates

.Merck &amp Co. has picked up possibilities on pair of Evaxion Biotech injection prospects, spending...

Enanta's RSV antiviral crushes viral lots in obstacle research

.Enanta Pharmaceuticals has actually linked its own breathing syncytial infection (RSV) antiviral to...

Biogen cans SAGE-324 cooperation after crucial shake stop working

.Biogen has provided the last ceremonies to its cooperation with Sage Therapies on SAGE-324, junking...

AbbVie Parkinson's medication from $8.7 B Cerevel buyout scores

.On the very same day that some Parkinson's ailment medicines are being cast doubt on, AbbVie has ac...

Arch shuts $3B-plus fund to nurture biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Resources Lifestyle Sciences, Arc Venture Allies...

Orion to use Aitia's 'digital identical twins' to find brand-new cancer medicines

.Finnish biotech Orion has snooped prospective in Aitia's "digital twin" technology to establish new...

Windtree's surprise med rears high blood pressure in most up-to-date phase 2 succeed

.While Windtree Rehabs has struggled to develop the monetary origins required to endure, a stage 2 s...

2 cancer biotechs combine, producing international impact

.OncoC4 is taking AcroImmune-- and its own internal scientific manufacturing capabilities-- under it...

Amgen reports initial period 3 gain for $400M chronic eczema medication

.Amgen has discussed (PDF) the first phase 3 records on its $400 million eczema drug, connecting the...